Editorial Comment to Local advanced adrenocortical cancer with a long‐term recurrence‐free survival treated with complete surgical excision and adjuvant therapy with a very low‐dos... by Koshiro Nishimoto

Get full text

Lower neutrophil‐to‐lymphocyte ratio and positive programmed cell death ligand‐1 expression are favorable prognostic markers in patients treated with pembrolizumab for urothelial c... by Yu Miyama, Go Kaneko, Koshiro Nishimoto, Masanori Yasuda

Get full text

Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivat... by Kent Kanao, Takayuki Takahashi, Yuta Umezawa, Takashi Okabe, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Masafumi Oyama

Get full text

Efficacy of abiraterone acetate for high-risk hormone-naïve metastatic prostate cancer: A comparison with combined androgen blockade therapy with bicalutamide and androgen deprivat... by Kent Kanao, Takayuki Takahashi, Yuta Umezawa, Takashi Okabe, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Masafumi Oyama

Get full text

Delayed nivolumab‐induced hepatotoxicity during pazopanib treatment for metastatic renal cell carcinoma: An autopsy case by Maki Todo, Hideyuki Kondo, Taiki Hayashi, Tsukasa Masuda, Takashi Okabe, Go Kaneko, Masafumi Oyama, Suguru Shirotake, Koshiro Nishimoto

Get full text

Case Study: A Japanese patient with metastatic renal cell carcinoma who achieved long‐term treatment‐free survival with pembrolizumab and axitinib in the KEYNOTE‐426 phase III tria... by Koshiro Nishimoto, Suguru Shirotake, Yu Miyama, Go Kaneko, Kent Kanao, Daisuke Igarashi, Takayuki Takahashi, Yuta Umezawa, Masanori Yasuda, Masafumi Oyama

Get full text

Progressive metastatic pheochromocytoma induced by multiple endocrine neoplasia type 2A with a lethal outcome by Koshiro Nishimoto, Noriaki Lukas Santo, Masato Yonamine, Kazuhiro Takekoshi, Go Kaneko, Suguru Shirotake, Hisayo Fukushima, Yoshitaka Okada, Masanori Yasuda, Akihiro Sakurai, Masafumi Oyama, Kento Kanao

Get full text

Identification of risk factors associated with oral 5-aminolevulinic acid-induced hypotension in photodynamic diagnosis for non-muscle invasive bladder cancer: a multicenter retros... by Hideo Fukuhara, Takahiro Nohara, Koshiro Nishimoto, Yutaka Hatakeyama, Yuki Hyodo, Yoshiyasu Okuhara, Masafumi Oyama, Atsushi Mizokami, Keiji Inoue, Hideyasu Matsuyama, on behalf of the Japan Urological Photodynamic Society

Get full text

A case in which bladder cancer invaded the ureteral orifice and was resected via photodynamic diagnosis‐assisted transurethral resection involving orally administered 5‐aminolevuli... by Keitaro Watanabe, Suguru Shirotake, Yuta Umezawa, Takayuki Takahashi, Takeshi Yamanaka, Noriaki LSanto, Takashi Okabe, Gou Kaneko, Katsuhiro Sano, Masanori Yasuda, Kent Kanao, Masafumi Oyama, Koshiro Nishimoto

Get full text

Familial Hyperaldosteronism Type 3 with a Rapidly Growing Adrenal Tumor: An In Situ Aldosterone Imaging Study by Nae Takizawa, Susumu Tanaka, Koshiro Nishimoto, Yuki Sugiura, Makoto Suematsu, Chisato Ohe, Haruyuki Ohsugi, Yosuke Mizuno, Kuniaki Mukai, Tsugio Seki, Kenji Oki, Celso E. Gomez-Sanchez, Tadashi Matsuda

Get full text

New risk stratification for adjuvant nivolumab for high‐risk muscle‐invasive urothelial carcinoma by Takafumi Saito, Kent Kanao, Kazuhiro Matsumoto, Keishiro Fukumoto, Daisuke Igarashi, Takayuki Takahashi, Go Kaneko, Suguru Shirotake, Koshiro Nishimoto, Ryuichi Mizuno, Masaru Ishida, Satoshi Hara, Mototsugu Oya, Masafumi Oyama

Get full text

Additional oncological benefit of photodynamic diagnosis with blue light cystoscopy in transurethral resection for primary non‐muscle‐invasive bladder cancer: A comparative study f... by Makito Miyake, Nobutaka Nishimura, Tomonori Nakahama, Koshiro Nishimoto, Masafumi Oyama, Yuto Matsushita, Hideaki Miyake, Hideo Fukuhara, Keiji Inoue, Keita Kobayashi, Hiroaki Matsumoto, Hideyasu Matsuyama, Tomomi Fujii, Yoshihiko Hirao, Kiyohide Fujimoto

Get full text

Oncological outcomes of dose reductions in cisplatin due to renal dysfunction for patients with metastatic urothelial carcinoma by Tetsushi Murakami, Eiji Kikuchi, Hiroki Ide, Yuta Umezawa, Takayuki Takahashi, Mizuki Izawa, Kyohei Hakozaki, Keisuke Shigeta, Koichiro Ogihara, Hiroaki Kobayashi, Kunimitsu Kanai, Takahiro Maeda, Shunsuke Yoshimine, Ryuichi Mizuno, Koshiro Nishimoto, Mototsugu Oya

Get full text

IMAGENE trial: multicenter, proof-of-concept, phase II study evaluating the efficacy and safety of combination therapy of niraparib with PD-1 inhibitor in solid cancer patients wit... by Taigo Kato, Nobuaki Matsubara, Masaki Shiota, Masatoshi Eto, Takahiro Osawa, Takashige Abe, Nobuo Shinohara, Yota Yasumizu, Nobuyuki Tanaka, Mototsugu Oya, Koshiro Nishimoto, Takuji Hayashi, Masashi Nakayama, Takahiro Kojima, Kenjiro Namikawa, Takao Fujisawa, Susumu Okano, Eisuke Hida, Yoshiaki Nakamura, Hideaki Bando, Takayuki Yoshino, Norio Nonomura

Get full text